XINCLAV 1.2 Price

Overview

Welcome to Dwaey, specifically on XINCLAV 1.2 Injection/Powder for page.
This medicine contains an important and useful components, as it consists of Co-amoxiclav.
XINCLAV 1.2 is available in the market in concentration 1200mg (1000mg + 200mg)/Vial and in the form of Injection/Powder for.

AUROBINDO PHARMA LIMITED is the producer of XINCLAV 1.2 and it is imported from INDIA, The most popular alternatives of XINCLAV 1.2 are listed downward .

Mode Of Action

Clavulanic acid has a high affinity for and binds to certain ?-lactamases that generally inactivate amoxicillin by hydrolyzing its ?-lactam ring. Combining clavulanate potassium with amoxicillin extends the antibacterial spectrum of amoxicillin to include many bacteria normally resistant to amoxicillin and other penicillins and cephalosporins.

Indication

• Bacterial infections
• Acute otitis media
• Acute bacterial sinusitis
• Endocarditis
• Dental abscess
• Community-acquired pneumonia
• Acute uncomplicated UTI
• Uncomplicated gonorrhea
• Severe or recurrent resp tract infections

Precaution

History of allergy especially to cephalosporins, infectious mononucleosis, severe renal impairment. Lactation: Drug excreted in breast milk; use caution

Side Effects

• >10% Diarrhea (3-34%; varies upon dose and regimen) 1-10% Diaper rash (3.5%)
• Mycosis (3.3%)
• Nausea (2-3%)
• Rash (1-3%)
• Vomiting (1-2.2%)
• Loose stool (1.6%)
• Candidiasis (1.4%)
• Vaginitis (1%) <1% Hypersensitivity reactions
• Anaphylaxis
• Anemia
• Thrombocytopenia
• Leukopenia
• Agranulocytosis
• Hepatoxicity
• AST/ALT elevation
• Pseudomembranous colitis
• Serum sickness
• Abdominal discomfort
• Cholestatic jaundice
• Flatulence Potentially Fatal: Anaphylactic reaction with CV collapse esp with parenteral use.

Contra indication

Penicillin allergy.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.